Valuation: ResMed, Inc.

Market Cap 3.22TCr 2.81TCr 2.65TCr 2.41TCr 4.51TCr 3,08900Cr 4.53TCr 32TCr 12TCr 1,57000Cr 12TCr 12TCr 5,05300Cr P/E 2027 *
19.3x
P/E 2028 * 17.6x
Enterprise Value 3.12TCr 2.72TCr 2.57TCr 2.34TCr 4.38TCr 2,99700Cr 4.39TCr 31TCr 12TCr 1,52400Cr 12TCr 11TCr 4,90300Cr EV / Sales 2027 *
5.37x
EV / Sales 2028 * 4.94x
Free-Float
75.13%
Yield 2027 *
1.18%
Yield 2028 * 1.3%
1 day-1.50%
1 week+3.08%
Current month-6.29%
1 month+2.28%
3 months+19.28%
6 months-1.27%
Current year-6.59%
1 week 220.94
Extreme 220.94
234.33
1 month 215.8
Extreme 215.8
242.4
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
284.87
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
293.81
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap. Importance
08/09/26 Exercice

Chief Executive Officer

14,973 0.0104%
02/09/26 Sell

Founder

-970 0.0007%
07/08/26 Exercice

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-1.50%+3.08%-17.67%+54.05% 3.22TCr
-1.04%+6.83%+35.41%+28.31% 24TCr
-0.32%+5.83%+8.47%-16.53% 15TCr
+2.55%+6.55%-9.75%+31.91% 14TCr
-0.48%+0.84%-55.88%-18.23% 6.28TCr
+0.01%+4.61%+18.39%+21.00% 5.09TCr
-1.69%-1.20%-20.18%-16.57% 4.82TCr
+0.08%+6.49%+22.61%+38.85% 4.41TCr
-1.88%+3.25%+37.62%+54.22% 4.14TCr
-2.27%+16.07%+132.57%+68.26% 3.62TCr
Average -0.65%+6.18%+15.16%+24.53% 8.45TCr
Weighted average by Cap. -0.31%+6.06%+13.82%+19.05%

Financials

2027 *2028 *
Net sales 581.12Cr 506.74Cr 478.48Cr 434.49Cr 814.07Cr 56TCr 817.47Cr 5.73TCr 2.21TCr 28TCr 2.18TCr 2.13TCr 91TCr 619.01Cr 539.78Cr 509.67Cr 462.82Cr 867.14Cr 59TCr 870.76Cr 6.11TCr 2.36TCr 30TCr 2.33TCr 2.27TCr 97TCr
Net income 164.31Cr 143.28Cr 135.29Cr 122.85Cr 230.17Cr 16TCr 231.13Cr 1.62TCr 625.36Cr 8.02TCr 617.23Cr 603.52Cr 26TCr 178.04Cr 155.25Cr 146.59Cr 133.11Cr 249.4Cr 17TCr 250.44Cr 1.76TCr 677.6Cr 8.69TCr 668.79Cr 653.94Cr 28TCr
Net Debt -95Cr -83Cr -79Cr -71Cr -133.74Cr -9.16TCr -134.3Cr -941.58Cr -363.35Cr -4.66TCr -358.63Cr -350.66Cr -15TCr -161.27Cr -140.62Cr -132.78Cr -120.57Cr -225.91Cr -15TCr -226.85Cr -1.59TCr -613.78Cr -7.87TCr -605.79Cr -592.34Cr -25TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370
Date Price Change Volume
18/26/18 $224.99 -1.50% 38,62,486
17/26/17 $228.42 +0.07% 10,85,530
16/26/16 $228.25 -0.52% 10,66,869
15/26/15 $229.44 +2.89% 16,41,047
14/26/14 $222.99 +2.16% 9,89,010
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
224.99USD
Average target price
247.56USD
Spread / Average Target
+10.03%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!